Gain Therapeutics Insider Trades

GANX

Track insider trading activity from Gain Therapeutics executives and directors. See which insiders are buying and selling GANX stock.

Trades Last 12 Months

GANX Price

All Insider Trades for Gain Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fuggetta Gianluca See Remark
Holding Value $89.5k 50,000 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93k 50,000 shares
$1.86
$1.79
Mack Gene Ceo, President
Holding Value $358k 200,000 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$372k 200,000 shares
$1.86
$1.79
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Islam Khalid Director
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Melincoff Gwen A Director
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Nicaise Claude Director
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Richman Eric I Director
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Alder Matthias Chief Executive Officer
Holding Value $37.8k 21,140 shares
Last Trade
Mar 26, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.7k 6,085 shares
$4.06
$1.79
Ballantyne Charles Evan Chief Financial Officer
Holding Value $179k 100,000 shares
Last Trade
Apr 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$479k 100,000 shares
$4.79
$1.79
Calabrese Salvatore Chief Financial Officer
Holding Value $89.5k 50,000 shares
Last Trade
Mar 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 50,000 shares
$4.84
$1.79
Bellotto Manolo President And General Manager
Holding Value $0 0 shares
Last Trade
Mar 17, 2021 Sale
No data
No data
$1.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up